English
  1. Home
  2. Stocks
  3. Tatva Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Tatva Chintan Pharma Chem

    Small Cap
    ₹1,117.1
    +17 (1.55%)
    18 May, 2024 15:16 BSE: 543321 NSE: TATVAISIN: INE0GK401011

    Start SIP in Tatva Chintan Pharma Chem

    Start SIP

    Tatva Chintan Pharma Chem Performance

    Day Range

    • Low 1,100
    • High 1,125
    ₹ 1,117

    52 Week Range

    • Low 1,061
    • High 1,888
    ₹ 1,117
    • Open Price1,111
    • Previous Close1,100
    • Volume6863

    Tatva Chintan Pharma Chem Share Price

    • Over 1 Month -9.57%
    • Over 3 Month -8.93%
    • Over 6 Month -25.76%
    • Over 1 Year -31.84%

    Tatva Chintan Pharma Chem Key Statistics

    P/E Ratio 86.1
    PEG Ratio -2.6
    Market Cap Cr 2,613
    Price to Book Ratio 3.5
    EPS 12.5
    Dividend 0.2
    Relative Strength Index 30.39
    Money Flow Index 4.97
    MACD Signal -19.25
    Average True Range 38.2
    Tatva Chintan Pharma Chem Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 948693106119
    Operating Expenses Qtr Cr 80747286104
    Operating Profit Qtr Cr 1412212015
    Depreciation Qtr Cr 67763
    Interest Qtr Cr 00333
    Tax Qtr Cr 4243-9
    Net Profit Qtr Cr 858816
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 386409
    Operating Expenses Annual Cr 312348
    Operating Profit Annual in Cr 6755
    Depreciation Cr 2610
    Interest Annual Cr 78
    Tax Annual Cr 13-2
    Net Profit Annual Cr 2940
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 10324
    Cash from Investing Activity Annual Cr -121-101
    Cash from Financing Annual Activity Cr 3138
    Net Cash Flow Annual Cr -40
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 726505
    Fixed Assets Annual Cr 503427
    Total Non Current Assets Annual Cr 521443
    Total Current Assets Annual Cr 294311
    Total Assets Annual Cr 815755
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 310228
    ROE Annual % 48
    ROCE Annual % 710
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2015
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 988497114125
    Operating Expenses Qtr Cr 83737693108
    Operating Profit Qtr Cr 1611202116
    Depreciation Qtr Cr 67763
    Interest Qtr Cr 00333
    Tax Qtr Cr 4234-9
    Net Profit Qtr Cr 10381017
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 401429
    Operating Expenses Annual Cr 325363
    Operating Profit Annual in Cr 6861
    Depreciation Cr 2610
    Interest Annual Cr 78
    Tax Annual Cr 13-1
    Net Profit Annual Cr 3045
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 9828
    Cash from Investing Activity Annual Cr -121-101
    Cash from Financing Annual Activity Cr 3138
    Net Cash Flow Annual Cr -36
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 737515
    Fixed Assets Annual Cr 503427
    Total Non Current Assets Annual Cr 521443
    Total Current Assets Annual Cr 298314
    Total Assets Annual Cr 819756
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 315232
    ROE Annual % 49
    ROCE Annual % 711
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1916
    Sign Up to Know More
    Invest in Tatva Chintan Pharma Chem

    Tatva Chintan Pharma Chem Technicals

    EMA & SMA

    Current Price
    ₹1,117.1
    +17 (1.55%)
    pointer
    • Bullish Moving Average
    • ___
    • 2
    • Bearish Moving Average
    • ___
    • 14
    • 20 Day
    • ₹1,166.85
    • 50 Day
    • ₹1,210.17
    • 100 Day
    • ₹1,285.10
    • 200 Day
    • ₹1,423.89
    • 20 Day
    • ₹1,188.68
    • 50 Day
    • ₹1,194.51
    • 100 Day
    • ₹1,296.16
    • 200 Day
    • ₹1,444.31

    Tatva Chintan Pharma Chem Resistance and Support

    PIVOT
    ₹1,101.37
    Resistance
    First Resistance 1,112.73
    Second Resistance 1,125.37
    Third Resistance 1,136.73
    RSI 30.39
    MFI 4.97
    MACD Single Line -19.25
    MACD -33.04
    Support
    First Support 1,088.73
    Second Support 1,077.37
    Third Supoort 1,064.73

    Tatva Chintan Pharma Chem Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 22,268 1,351,222 60.68
    Week 28,786 1,851,253 64.31
    1 Month 17,850 997,293 55.87
    6 Month 32,394 1,822,822 56.27

    Tatva Chintan Pharma Chem Result Highlights

    Tatva Chintan Pharma Chem Synopsis

    NSE-Chemicals-Basic

    Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 403.04 Cr. and Equity Capital is Rs. 22.17 Cr. for the Year ended 31/03/2023. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.
    Market Cap 2,573
    Sales 379
    Shares in Float 0.65
    No of funds 35
    Yield 0.18
    Book Value 3.55
    U/D Vol ratio 1
    LTDebt / Equity 1
    Alpha -0.21
    Beta 0.5

    Tatva Chintan Pharma Chem Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23
    Promoters 72.02%72.02%72.02%
    Mutual Funds 12.84%13.05%13.54%
    Insurance Companies 0.11%
    Foreign Portfolio Investors 3.65%4.21%4.4%
    Individual Investors 10.49%9.39%8.72%
    Others 1.33%1.21%

    Tatva Chintan Pharma Chem Management

    Name Designation
    Mr. Chintan Nitinkumar Shah Chairman & Managing Director
    Mr. Ajaykumar Mansukhlal Patel Whole Time Director
    Mr. Shekhar Rasiklal Somani Whole Time Director
    Dr. Manher Chimanlal Desai Independent Director
    Mr. Subhash Ambubhai Patel Independent Director
    Dr. Avani Rajesh Umatt Independent Director

    Tatva Chintan Pharma Chem Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Tatva Chintan Pharma Chem Corporate Action

    Date Purpose Remarks
    2024-05-03 Audited Results & Final Dividend
    2024-01-20 Quarterly Results
    2023-11-02 Quarterly Results
    2023-08-04 Quarterly Results
    2023-07-11 Preferential issue of shares
    Date Purpose Remarks
    2022-09-09 FINAL Rs.2.00 per share(20%)Final Dividend

    Tatva Chintan Pharma Chem MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 50,423
    SBI Magnum Midcap Fund Regular Growth 17,910
    Nippon India ELSS Tax Saver Fund Growth 14,932
    Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth 8,546
    ICICI Prudential Smallcap Fund Growth 7,659

    Tatva Chintan Pharma Chem FAQs

    What is Share Price of Tatva Chintan Pharma Chem ?

    Tatva Chintan Pharma Chem share price is ₹1,117 As on 18 May, 2024 | 15:02

    What is the Market Cap of Tatva Chintan Pharma Chem ?

    The Market Cap of Tatva Chintan Pharma Chem is ₹2613.1 Cr As on 18 May, 2024 | 15:02

    What is the P/E ratio of Tatva Chintan Pharma Chem ?

    The P/E ratio of Tatva Chintan Pharma Chem is 86.1 As on 18 May, 2024 | 15:02

    What is the PB ratio of Tatva Chintan Pharma Chem ?

    The PB ratio of Tatva Chintan Pharma Chem is 3.5 As on 18 May, 2024 | 15:02

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.